论文部分内容阅读
目的:本文主要分析了阿莫西林、克拉霉素及奥美拉唑三种药物的联合治疗消化溃疡的临床效果,希望能够为消化性溃疡提供有价值的临床依据。方法 :本文收集了患有消化性溃疡的50例患者作为研究样本,将50人平均随机的分成对照组和实验组,对照组使用阿莫西林、雷尼替丁及克拉霉素对患者进行治疗,实验组采用阿莫西林、克拉霉素及奥美拉唑三种药物联合疗法,最后比较分析两组在疗效上的差异。结果 :经过观察统计,实验组的总有效率为90%,治愈率为68%,比对照组的76%的有效率和52%治愈率要高出很多,具有明显的统计学意义。三联法治疗复发率为8%,比对照组的24%低很多,具有统计学差异。结论 :奥美拉唑、阿莫西林、克拉霉素二三联疗法治疗消化性溃疡疗效显著,值得在临床推广。
OBJECTIVE: In this paper, the clinical effects of amoxicillin, clarithromycin and omeprazole in the combination therapy of peptic ulcer were analyzed in the hope of providing a valuable clinical basis for peptic ulcer. Methods: In this study, 50 patients with peptic ulcer were collected as research samples, 50 were randomly divided into control group and experimental group. Patients in control group were treated with amoxicillin, ranitidine and clarithromycin , The experimental group using amoxicillin, clarithromycin and omeprazole three drug combination therapy, the final comparison analysis of the two groups in the difference in efficacy. Results: After observation and statistics, the total effective rate of the experimental group was 90%, the cure rate was 68%, which was significantly higher than 76% of the control group and 52% of the cure rate, with significant statistical significance. The triple therapy treatment of recurrence rate was 8%, 24% lower than the control group, with a statistically significant difference. Conclusion: Omeprazole, amoxicillin and clarithromycin in the treatment of peptic ulcer with significant curative effect are worthy of clinical promotion.